1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. FRANCE AI-DRIVEN HYPOTHESIS GENERATION MARKET BY SOFTWARE TYPE
5.1. Introduction
5.2. AI-Powered Literature Mining Tools
5.3. Graph-Based Hypothesis Generation Platforms
5.4. Domain-Specific Predictive Modeling Tools
5.5. Multimodal AI Platforms
5.6. Others
6. FRANCE AI-DRIVEN HYPOTHESIS GENERATION MARKET BY APPLICATION AREA
6.1. Introduction
6.2. Drug Discovery & Life Sciences
6.3. Healthcare & Diagnostics
6.4. Materials & Chemical Research
6.5. Financial & Business Analytics
6.6. Academic
7. FRANCE AI-DRIVEN HYPOTHESIS GENERATION MARKET BY DEPLOYMENT MODE
7.1. Introduction
7.2. Cloud-Based
7.3. On-Premise
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Owkin
9.2. DBV Technologies
9.3. Quantum Biosystems
9.4. Cyclica
9.5. PharmaCaddie
9.6. Inato
9.7. Volta AI
9.8. Valneva
9.9. Adocia
9.10. HCS Pharma
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES